SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?


To: harkenman who wrote (55)5/11/1999 12:12:00 AM
From: James Silverman  Respond to of 362
 
Hark,
I don't own shares in TTP. I do somewhat follow them. In my opinion its a leveraged play on iloperidone, which they licensed to Novartis, and little more. Certainly an interesting speculation here particularly if one has the patience---maybe 2 years---to see how iloperidone turns out.
Still own and like BRL. Still don't like DRMD--congrats on its nice move however.

Jim